Literature DB >> 25792646

Anti-inflammatory activity of the artificial antioxidants 2-tert-butyl-4-methoxyphenol (BHA), 2,6-di-tert-butyl-4-methylphenol (BHT) and 2,4,6-tri-tert-butylphenol (TBP), and their various combinations.

Yukio Murakami1, Akifumi Kawata2, Tadashi Katayama2, Seiichiro Fujisawa2.   

Abstract

BACKGROUND/AIM: The artificial complex phenols, 2-tert-butyl-4-methoxyphenol (BHA), 2,6-di-tert-butyl-4-methylphenol (BHT) and 2,4,6-tri-tert-butylphenol (TBP) exert efficient antioxidant activity; however, they are considerable toxic and potentially tumor-promoting. These phenols, particularly in combinations, have enhanced antioxidant activity due to synergistic interactions and produce bioactive intermediates such as quinone methide. We investigated the anti-inflammatory activity of BHA, BHT and TBP, and combinations of BHT/BHA (in molar ratios of 1:1, 1:2, 1:3 and 2:1), BHT/TBP (1:1), and BHA/TBP (1:1), using gene-expression systems for cyclooxygenase-2 (Cox2) and tumor necrosis facto-alpha (Tnfa) in RAW264.7 cells.
MATERIALS AND METHODS: The inhibitory effects of BHA, BHT and TBP on expression of Cox2 and Tnfa genes upon stimulation with Escherichia coli lipopolysaccharide (LPS) or Porphyomonas gingivalis (Pg) fimbriae were determined using real-time polymerase chain reaction.
RESULTS: The inhibitory effect on expression of Cox2 and Tnfa genes upon stimulation with LPS and fimbriae was greatly enhanced by the combination of two antioxidants (molar ratio 1:1), BHT/BHA. In addition, that of the Cox2 gene, but not of Tnfa gene was slightly enhanced by a combination of equimolar BHT/TBP and BHA/TBP. None of the antioxidants alone exerted any anti-inflammatory activity upon stimulation with LPS, but a slight anti-inflammatory activity was observed upon stimulation with Pg fimbriae. The inhibitory effect of the BHT/BHA combination on expression of Cox2 mRNA upon stimulation with LPS was investigated at afferent molar ratios, and a molar ratio of 1:1 was found to have considerably less effect than a molar ratio of 1:2 or 2:1. The 1:3 combination had no effect.
CONCLUSION: The combination of BHT and BHA at a molar ratio of 0.5-2 exerts potent anti-inflammatory activity. This anti-inflammatory activity on the generation of inflammatory mediators in LPS-activated RAW264.7 cells may be attributable to complex synergistic antioxidant activity of the combination of BHT and BHA. Our results suggest the potential usefulness of the BHT/BHA combination at an appropriate molar ratio as an antioxidant in foods and pharmaceuticals, whereas either antioxidant alone is unlikely to be effective.
Copyright © 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  BHA; BHT; COX2; Phenolic antioxidants; RAW264.7 cells; TNFα; anti-inflammatory activity; antioxidant combination; cytotoxicity

Mesh:

Substances:

Year:  2015        PMID: 25792646

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  4 in total

Review 1.  Natural Sources and Bioactivities of 2,4-Di-Tert-Butylphenol and Its Analogs.

Authors:  Fuqiang Zhao; Ping Wang; Rima D Lucardi; Zushang Su; Shiyou Li
Journal:  Toxins (Basel)       Date:  2020-01-06       Impact factor: 4.546

Review 2.  Low-Molecular-Weight Synthetic Antioxidants: Classification, Pharmacological Profile, Effectiveness and Trends.

Authors:  Mihaela Stoia; Simona Oancea
Journal:  Antioxidants (Basel)       Date:  2022-03-26

3.  Active Anti-Inflammatory and Hypolipidemic Derivatives of Lorazepam.

Authors:  Panagiotis Theodosis-Nobelos; Georgios Papagiouvannis; Panos N Kourounakis; Eleni A Rekka
Journal:  Molecules       Date:  2019-09-09       Impact factor: 4.411

4.  Effects of Vitex trifolia L. leaf extracts and phytoconstituents on cytokine production in human U937 macrophages.

Authors:  Hai-Ning Wee; Soek-Ying Neo; Deepika Singh; Hui-Chuing Yew; Zhi-Yu Qiu; Xin-Rong Cheryl Tsai; Sin-Yi How; Keng-Yan Caleb Yip; Chay-Hoon Tan; Hwee-Ling Koh
Journal:  BMC Complement Med Ther       Date:  2020-03-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.